Condition

Allergic Asthma clinical trials and research

• 7Clinical trials
• 2New in 30 days
• 7Countries

Newest Allergic Asthma clinical trials

All recruiting trials (7)

• Mannan-Conjugated Allergoids for House Dust M mite Allergy

  A new treatment named EP-088_MM09 is being tested to see if it can reduce nasal and eye allergy symptoms (and possibly asthma) in people aged 12 to 65 who are allergic to house dust mites, compared with a placebo.

  Recruiting at 2 sites Phase 3 Inmunotek S.L. · Covilha, Castelo Branco District and 15 other locations · NCT07904195

• Mannan-conjugated Allergoids for House Dust Mite Allergy

  A new treatment called EP-088_MM09 is being tested to see if it can reduce allergy symptoms in people with house dust mite–related nasal allergy, with or without mild asthma.

  Recruiting at 4 sites Phase 3 Inmunotek S.L. · Coimbra and 15 other locations · NCT07904052

• Switching to Omlyclo® (omalizumab biosimilar) for adults with chronic spontaneous urticaria or severe allergic asthma

  This will try switching adults who are stable on reference omalizumab to the biosimilar Omlyclo® to see if disease control and patient satisfaction stay the same over 12 months.

  Recruiting Celltrion HealthCare France · Montpellier · NCT07425639

• LP-003 injection for adults with moderate to severe allergic asthma

  This trial tests whether LP-003 injection helps adults with moderate to severe allergic asthma by comparing it with omalizumab and placebo.

  Recruiting Phase 2 Longbio Pharma · Shanghai · NCT07342803

• Creating a risk assessment tool for thunderstorm asthma (CARISTA)

  This project will test whether lung tests, allergy blood markers and daily symptom tracking can predict which adults with hay fever in South‑Eastern Australia will have seasonal or thunderstorm-related asthma attacks over two spring seasons.

  Recruiting at 6 sites University of Melbourne · Albury, New South Wales and 5 other locations · NCT07055542

• Intralymphatic cat-allergy immunotherapy for people with cat-induced rhinitis and asthma

  This trial tests whether three to four ultrasound-guided injections of a cat-allergy vaccine into an inguinal lymph node are safe and trigger helpful immune responses in adults with cat-caused allergic rhinitis, with or without asthma.

  Recruiting Phase 1/2 University of Zurich · Zurich · NCT06960382

• Evaluating FB825 for allergic asthma in adults

  This study is testing a new treatment called FB825 to see if it can help adults with moderate-to-severe allergic asthma breathe better.

  Recruiting at 13 sites Phase 2 Oneness Biotech Co., Ltd. · Kaohsiung City and 12 other locations · NCT05008965

Related topics

Quick answers

How many Allergic Asthma clinical trials are recruiting right now?

7, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in Portugal (2 trials), Spain (2 trials), Australia (1 trial), France (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →